Assertio Holdings, Inc. (NASDAQ:ASRT) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Matthew Kreps – Darrow Associates, IRHeather Mason – Interim CEOAjay Patel – CFOPaul Schwichtenberg – Chief Commercial Officer Conference Call Participants Jim Sidoti – Sidoti & CompanyThomas Flaten – Lake Street Capital Markets Operator Good afternoon, and welcome…
MediaProduction Investment thesis Okay, admitted: This one’s a troubled child. At one point in 2015, the common stock of Assertio Holdings, Inc. (NASDAQ:ASRT) traded at ~$130. Less than a year later it had lost more than half of that value, and with the exception of a spike in late 2016, Assertio’s share price has known…
May Lim Assertio Holdings (NASDAQ:ASRT) stands at a pivotal juncture in its history. A mere 3.5 years ago, Assertio’s portfolio was heavily reliant on ZIPSOR and CAMBIA, but today, these once-dominant assets constitute only a fraction of the company’s net product sales. Furthermore, the company deliberately exited the opioid business, marked by the discontinuation of…